Careers  |  Sign In  |  Register  |   Twitter

Amyotrophic Lateral Sclerosis: Treating the Disease and Providing Patient‑centered Care

 
Course List

  • CME Information

Provider Statement

This continuing medical education activity is provided by Vindico Medical Education

Support Statement

This activity is supported by an educational grant from Mitsubishi Tanabe Pharma America, Inc.

Target Audience

The intended audience for this activity is neurologists, internists, and other health care professionals involved in the treatment of patients with amyotrophic lateral sclerosis (ALS).

Learning Objectives

Upon successful completion of this educational activity, participants should be better able to:

  • Assess edaravone; its mechanisms of action, similarities, and differences from riluzole; and how to use it in clinical practice to reduce the progression of amyotrophic lateral sclerosis (ALS).
  • Assess the use of multidisciplinary approaches and patient-centered decision making in the care of patients with ALS.

Faculty

Terry D. Heiman-Patterson, MD
Professor of Neurology
Director of the MDA ALS Center of Hope
Temple University Lewis Katz School of Medicine
Philadelphia, PA

Richard Bedlack, MD, PhD
Professor of Neurology
ALS Clinic Director
Duke University
Durham, NC

Reviewer

Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP

Accreditation

Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Vindico Medical Education designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit(s)™, 0.25 credits per video. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This enduring material is approved for 1 year from the date of original release, October 11, 2018 to October 11, 2019.

How to Participate in This Activity and Obtain CME Credit

To participate in this CME activity, you must read the objectives, answer the pretest questions, view the videos, and complete the CME posttest and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 100% of the posttest questions correctly for each video. If a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ Certificate.

Disclosures

In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all CME providers are required to disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of CME content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the CME activity content over which the individual has control. Relationship information appears below.

The authors disclose that they do have significant financial interests in any products or class of products discussed directly or indirectly in this activity, including research support.

Faculty members report the following relationship(s):

Terry D. Heiman-Patterson, MD
Consulting Fee: Mitsubishi Tanabe
Publications Committee: Cytokinetics

Richard Bedlack, MD, PhD
Consulting Fee: ALSA, Avanir, Brainstorm, Cytokinetics, Mallinkrodt, Neuraltus
Contracted Research: ALSA, Cytokinetics, GlaxoSmithKline, MNDA, Neuraltus, Orion, Ultragenyx

Reviewers report the following relationship(s):

Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
No relevant financial relationships to disclose.

Vindico Medical Education staff report the following relationship(s):
No relevant financial relationships to disclose.

Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.

Unlabeled and Investigational Usage

The audience is advised that this continuing medical education activity may contain references to unlabeled uses of US Food and Drug Administration (FDA)-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non–FDA-approved or investigational use of products/devices.

Copyright Statement

Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2018 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of Vindico Medical Education continuing medical education activities does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.

CME Questions?

Contact us at CME@VindicoCME.com